Announcements
- Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
- Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
- Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
- Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
- Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 0.00 |
Low | 0.00 |
Bid | -- |
Offer | -- |
Previous close | 0.00 |
Average volume | -- |
---|---|
Shares outstanding | 16.92m |
Free float | 16.52m |
P/E (TTM) | -- |
Market cap | 66.34m USD |
EPS (TTM) | -12.43 USD |
Data delayed at least 15 minutes, as of Nov 16 2023.
More ▼